IL10 and neoplasm: Additionally, Treg IL-10 production regulated the Th17 response in the TME [180], with TME-specific type I IFN signaling promoting Treg activation and IL-10 synthesis to counteract Th17 inflammation and prevent tumor development or autoimmunity [181,182,183].